dihexa cancer risk hgf c-met Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity Joints fda warning compounded peptides Quantity of Syringe/Needle Combos:100 Syringes & Needles
SKU: 22087725151
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19